Ambily Nath Indu Viswanath

In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level

Ae Nim Pae, TaeHun Kim, Kyoung Tai No, 2017, Journal of Computer-Aided Molecular Design.

Psoralidin, a coumestan analogue, as a novel potent estrogen receptor signaling molecule isolated from Psoralea corylifolia.

Ambily Nath Indu Viswanath, A. Pae, Jong Hoon Park, 2014, Bioorganic & medicinal chemistry letters.

Resistance by allostery: a novel perspective for eg5-targeted drug design.

Ambily Nath Indu Viswanath, A. Pae, 2013, Journal of medicinal chemistry.

Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).

Ambily Nath Indu Viswanath, H. Seol, D. Nam, 2015, European journal of medicinal chemistry.

Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model

Ambily Nath Indu Viswanath, Ashwini M. Londhe, Ki Duk Park, 2020, Neuropharmacology.

Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: Design, synthesis, kinase assay, cell-based assay, and molecular docking.

Ambily Nath Indu Viswanath, A. Pae, Kyung-Tae Lee, 2015, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists.

Ambily Nath Indu Viswanath, H. Rhim, A. Pae, 2015, Bioorganic & medicinal chemistry.

GRP78‐targeted in‐silico virtual screening of novel anticancer agents

Ambily Nath Indu Viswanath, A. Pae, S. Seo, 2018, Chemical biology & drug design.

Identification of the first in silico‐designed TREK1 antagonists that block channel currents dose dependently

Ambily Nath Indu Viswanath, Seo Yun Jung, Ki Duk Park, 2016, Chemical biology & drug design.